ONCONOVA THERAPEUTICS INC's ticker is ONTXXXXX and the CUSIP is 68232V108. A total of 25 filers reported holding ONCONOVA THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $163,000 | +13.2% | 280,704 | +86.8% | 0.00% | – |
| Q4 2015 | $144,000 | +53.2% | 150,300 | +116.3% | 0.00% | – |
| Q3 2015 | $94,000 | -55.7% | 69,477 | -22.3% | 0.00% | – |
| Q2 2015 | $212,000 | -19.7% | 89,400 | -18.2% | 0.00% | -100.0% |
| Q1 2015 | $264,000 | +23.9% | 109,347 | +68.8% | 0.00% | 0.0% |
| Q4 2014 | $213,000 | -13.4% | 64,760 | +13.2% | 0.00% | 0.0% |
| Q3 2014 | $246,000 | -68.4% | 57,200 | -60.1% | 0.00% | -50.0% |
| Q2 2014 | $778,000 | – | 143,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. | 120,000 | $1,378,000 | 0.38% |
| EMERALD ADVISERS, LLC | 367,369 | $4,217,000 | 0.23% |
| WEATHERBIE CAPITAL, LLC | 176,462 | $2,026,000 | 0.19% |
| Catalyst Capital Advisors LLC | 25,000 | $287,000 | 0.09% |
| Eventide Asset Management | 23,000 | $264,000 | 0.08% |
| Weiss Multi-Strategy Advisers LLC | 204,400 | $2,347,000 | 0.05% |
| A.R.T. Advisors, LLC | 42,741 | $490,000 | 0.03% |
| KINGS POINT CAPITAL MANAGEMENT | 5,500 | $63,000 | 0.02% |
| SSI INVESTMENT MANAGEMENT LLC | 21,470 | $247,000 | 0.02% |
| Marshall Wace North America L.P. | 14,439 | $166,000 | 0.00% |